Our Work

The Ewing Sarcoma Institute is a catalyst and a force multiplier—strategically coordinating, investing, and driving change at a system-wide level. We are here to radically transform the future of this disease—starting now.

Our Approach

The Ewing Sarcoma Institute was formed through a catalytic philanthropic gift from Charles Nearburg. Under the guidance of the leading Ewing Sarcoma researchers from across the globe, and in community with patients, families, and advocates, ESI is designed exclusively to accelerate research, expand trials, and ensure that every Ewing Sarcoma patient has access to the best possible care and emerging therapies.

Drive Scientific Discovery to Accelerate New Treatment Options

Unite the global research community to establish a strategic, high-impact research agenda.

Accelerate Clinical Trial Development and Access to New Therapies

Accelerate the discovery, development, and accessibility of more effective treatments for patients with Ewing Sarcoma.

Empower Patients and Families with Knowledge and Support

Build a deeply connected, welcoming community where patients, families, researchers, and advocates come together to support one another, share knowledge, and take action.

Institutions Represented on Our Strategic Advisory Board

Institutional Collaborators

Ongoing Clinical Trials & Breakthrough Research

We support and highlight cutting-edge clinical trials and research focused on advancing Ewing Sarcoma treatments. By accelerating innovation and expanding patient access, we aim to drive meaningful progress toward more effective and targeted therapies.